The Evidence REVEAL Study: Exploring the Use of Real‐World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry
Author:
Affiliation:
1. Technopolis Group Brighton UK
2. Technopolis Group Amsterdam the Netherlands
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2103
Reference58 articles.
1. The use of real-world data in cancer drug development
2. Hybrid studies and other approaches to generate real world evidence;Al‐Dakkak I.;Regul. Rapp.,2018
3. FDA Framework for FDA’s Real‐World Evidence Program (2018).
4. 21st Century Cures Act 42 USC (2016).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Navigating the unknown: how to best ‘reflect’ standard of care in indications without a dedicated treatment pathway in health technology assessment submissions;Journal of Comparative Effectiveness Research;2024-02
2. Impact of Novel Remediation Technology: Significant Role in the Removal of Toxic Pollutants via Sustainable Approaches;Industrial Microbiology and Biotechnology;2024
3. Recent advances in the treatment of wastewater contaminated with pharmaceutical pollutants: a critical review;Euro-Mediterranean Journal for Environmental Integration;2023-11-15
4. Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications;Therapeutic Innovation & Regulatory Science;2023-09-08
5. Principles for Good Practice in the Conduct of Non-interventional Studies: The View of Industry Researchers;Therapeutic Innovation & Regulatory Science;2023-07-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3